Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2022
  2. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

    Rossing, Peter, Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., Macisaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Diabetes Care. 45, 4, p. 888-897 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., McGill, J. B., Rosas, S. E., Joseph, A., Gebel, M., Roberts, L., Scheerer, M. F., Bakris, G. L. & Agarwal, R., 2022, In: Diabetes Care. 45, 12, p. 2991-2998 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    FIDELIO-DKD Investigators, F. I., 2022, In: Kidney International Reports. 7, 1, p. 36-45

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

    Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, Rosano, G. M. C., Rossing, Peter, Rydén, L., Santilli, F., Schumm-Draeger, P., Vandvik, P. O., Vilsbøll, Tina, Wanner, C., Wysham, C. & Standl, E., 2022, In: Cardiovascular Diabetology. 21, 1, 50.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journalLetterResearchpeer-review

ID: 12937790